The importance of pharmacological blockade of Src kinase activity in suppressing metastatic spreading was confirmed by the demonstration that decreased expression of endogenous Src inhibited pancreatic cancer cell progression through an anchorage-independent manner. This evidence concerns the gene SRC and familial pancreatic carcinoma.